← Back to patent-cliff list
bis-octanoyl (R)-1,3-butanediol (C8 ketone di-ester)
Tier C — Watch / tradebis-octanoyl (R)-1,3-butanediol (C8 ketone di-ester)
-
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Updating
Indications (approved)：Non-alcoholic steatohepatitis, Obesity
Regional status
US
Phase II
2025-09-26
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of bis-octanoyl (R)-1,3-butanediol (C8 ketone di-ester)?
Approved indications include: Non-alcoholic steatohepatitis, Obesity.
When does the bis-octanoyl (R)-1,3-butanediol (C8 ketone di-ester) patent expire?
No public expiry year is available for bis-octanoyl (R)-1,3-butanediol (C8 ketone di-ester) yet; this page updates once verified.
How do I get a quote for bis-octanoyl (R)-1,3-butanediol (C8 ketone di-ester) intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-30